OCC 0.00% 38.5¢ orthocell limited

....and I thought the Kohler report sent the stock higher...

  1. 7,533 Posts.
    lightbulb Created with Sketch. 6794
    ....and I thought the Kohler report sent the stock higher nicely....

    https://hotcopper.com.au/data/attachments/5207/5207260-db908ea8d648564b6df83ab6676e6853.jpg


    This was, you will recall, the same type of study that saw Striate quickly approved by both the TGA and FDA. Long overdue, but coming at last. Remplir on the Aussie mkt already, hopefully US and EU to quickly follow in 2024. This product on the Aussie prosthesis list for near $1,400 remember. This could potentially bring even more eventual revenues than Striate with Bio Horizons.......
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.